-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Protagonist Therapeutics, Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
- Protagonist Therapeutics, Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$27.4M, a 20.1% increase year-over-year.
- Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$70.2M, a 35% increase from 2022.
- Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$108M, a 0.25% decline from 2021.
- Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$108M, a 48.8% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)